Center-Authored Papers

Filters: Author is Gralow, Julie R  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Calip GS, Hubbard RA, Stergachis A, Malone KE, Gralow JR, Boudreau DM.  2014.  Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.. Pharmacoepidemiology and drug safety. Abstract
Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP et al..  2009.  Adjuvant chemotherapy in older women with early-stage breast cancer.. The New England journal of medicine. 360(20):2055-65. Abstract
Kaufman PA, Bloom KJ, Burris H, Gralow JR, Mayer M, Pegram M, Rugo HS, Swain SM, Yardley DA, Chau M et al..  2014.  Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer.. Cancer. Abstract
Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow JR et al..  2008.  Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(28):4672-8. Abstract
B
El Saghir NS, Adebamowo CA, Anderson BO, Carlson RW, Bird PA, Corbex M, Badwe RA, Bushnaq MA, Eniu A, Gralow JR et al..  2011.  Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S3-11. Abstract
C
Moinpour CM, Donaldson GW, Davis KM, Potosky AL, Jensen RE, Gralow JR, Back AL, Hwang JJ, Yoon J, Bernard DL et al..  2016.  The challenge of measuring intra-individual change in fatigue during cancer treatment.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. Abstract
Smerage JB, Barlow WE, Hortobagyi GN, Winer EP, Leyland-Jones B, Srkalovic G, Tejwani S, Schott AF, O'Rourke MA, Lew DL et al..  2014.  Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Jia N, Cormack FC, Xie B, Shiue Z, Najafian B, Gralow JR.  2015.  Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.. BMC cancer. 15:535. Abstract
Mehta RS, Barlow WE, Albain KS, Vandenberg TA, Dakhil SR, Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB et al..  2012.  Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44. Abstract
Rodler E, Korde L, Gralow JR.  Submitted.  Current Treatment Options in Triple Negative Breast Cancer.. Breast disease. 32(1-2):99-112. Abstract
D
Van Poznak CH, Darke A, Moinpour CM, Bagramian RA, Schubert MM, Gralow JR, Wade JL, Unger JM.  2016.  Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Abstract
E
Wirtz HS, Calip GS, Buist DSM, Gralow JR, Barlow WE, Gray S, Boudreau DM.  2017.  Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.. American journal of epidemiology. 185(8):661-672. Abstract
F
Wirtz HS, Boudreau DM, Gralow JR, Barlow WE, Gray S, Bowles EJA, Buist DSM.  2014.  Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors.. Breast cancer research and treatment. 143(3):541-50. Abstract
Linden HM, Kurland BF, Peterson LM, Schubert EK, Gralow JR, Specht JM, Ellis GK, Lawton TJ, Livingston RB, Petra PH et al..  2011.  Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(14):4799-805. Abstract
Wirtz HS, Buist DSM, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJA, Fujii M, Boudreau DM.  2013.  Frequent antibiotic use and second breast cancer events.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1588-99. Abstract
G
Perez EA, Thompson AE, Ballman KV, Anderson KS, Asmann YW, Kalari KR, Eckel-Passow JE, Dueck AC, Tenner KS, Jen J et al..  2015.  Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(7):701-8. Abstract
H
Gralow JR, Lipton A, Stopeck AT.  2011.  How Do We Define Efficacy in Comparing Osteoclast-Targeted Agents in Metastatic Breast Cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3591-3592.
Jensen MP, Gralow JR, Braden A, Gertz KJ, Fann JR, Syrjala KL.  2012.  Hypnosis for symptom management in women with breast cancer: a pilot study.. The International journal of clinical and experimental hypnosis. 60(2):135-59. Abstract
I
Perez EA, Dueck AC, McCullough AE, Chen B, Geiger XJ, Jenkins RB, Lingle WL, Davidson NE, Martino S, Kaufman PA et al..  2013.  Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(17):2115-22. Abstract
Koon KP, Lehman CD, Gralow JR.  2013.  The importance of survivors and partners in improving breast cancer outcomes in Uganda.. Breast (Edinburgh, Scotland). Abstract
Thariani R, Henry NL, Ramsey SD, Blough DK, Barlow B, Gralow JR, Veenstra DL.  2013.  Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis Journal of Comparative Effectiveness Research. 2(3):325-334.
K
Doot RK, Muzi M, Peterson LM, Schubert EK, Gralow JR, Specht JM, Mankoff DA.  2010.  Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 51(4):521-7. Abstract
M
Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, Gralow JR.  2008.  Major depression after breast cancer: a review of epidemiology and treatment.. General hospital psychiatry. 30(2):112-26. Abstract
Calip GS, Malone KE, Gralow JR, Stergachis A, Hubbard RA, Boudreau DM.  2014.  Metabolic syndrome and outcomes following early-stage breast cancer.. Breast cancer research and treatment. 148(2):363-77. Abstract
N
Gralow JR, Biermann SJ, Farooki A, Fornier MN, Gagel RF, Kumar RN, Shapiro CL, Shields A, Smith MR, Srinivas S et al..  2009.  NCCN Task Force Report: Bone Health in Cancer Care.. Journal of the National Comprehensive Cancer Network : JNCCN. 7 Suppl 3:S1-S32;quizS33-S35. Abstract